Asymptomatic immunoglobulin light chain amyloidosis (AL) at the time of diagnostic bone marrow biopsy in newly diagnosed patients with multiple myeloma and smoldering myeloma. A series of 144 cases and a review of the literature

Annals of Hematology

Volumn 90, Issue 1, 2011, Pages 101-106

  Siragusa, Sergio ^b   Morice, William ^a   Gertz, Morie A ^a   Kyle, Robert A ^a   Greipp, Philip R ^a   Lust, John A ^a   Witzig, Thomas E ^a   Lacy, Martha Q ^a   Zeldenrust, Steven R ^a   Rajkumar, S Vincent ^a   Russell, Stephen J ^a   Hayman, Suzanne R ^a   Buadi, Francis ^a   Kumar, Shaji K ^a   Dingli, David ^a   Dispenzieri, Angela ^a  

^a MAYO CLINIC ROCHESTER   (United States)

^b NONE

Author keywords

Amyloid; Asymptomatic; Bone marrow biopsy; Multiple myeloma; Smoldering myeloma

Indexed keywords

ALKALINE PHOSPHATASE; AMYLOID; BETA 2 MICROGLOBULIN; C REACTIVE PROTEIN; CALCIUM; CONGO RED; CREATININE; HEMOGLOBIN; IMMUNOGLOBULIN KAPPA CHAIN; IMMUNOGLOBULIN LIGHT CHAIN; MELPHALAN; PREDNISONE; PROTEIN; PROTEIN P53; SERUM ALBUMIN;

ADULT; AGE; AGED; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; AMYLOIDOSIS; ANEMIA; APPLE GREEN BIREFRINGENCE; ARTICLE; ASYMPTOMATIC DISEASE; BIREFRINGENCE; BLEEDING; BONE MARROW BIOPSY; BONE PAIN; CHROMOSOME DELETION 13; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLAUDICATION; CREATININE BLOOD LEVEL; DISEASE SEVERITY; ELECTROPHORESIS; FATIGUE; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; FRACTURE; GENE DELETION; GENE TRANSLOCATION; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERCALCEMIA; KARYOTYPE 46,XX; KIDNEY FUNCTION TEST; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MONOCLONAL IMMUNOGLOBULINEMIA; MONOSOMY; MULTIPLE FRACTURE; MULTIPLE MYELOMA; PAIN; PARESTHESIA; PLASMA CELL; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN URINE LEVEL; PROTHROMBIN TIME; SKIN BRUISING; SMOLDERING MULTIPLE MYELOMA; STAINING; STEATORRHEA; THROMBOCYTE COUNT; TONGUE; TRISOMY; TRISOMY 11; TRISOMY 13; TRISOMY 15; TRISOMY 17; TRISOMY 3; TRISOMY 7; TRISOMY 9; VOICE; WEAKNESS; WEIGHT REDUCTION;

ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; AMYLOIDOSIS; ASYMPTOMATIC DISEASES; BIOPSY; BONE MARROW; FEMALE; HUMANS; IMMUNOGLOBULIN LIGHT CHAINS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; RETROSPECTIVE STUDIES;

EID: 78651291107     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-010-1028-8     Document Type: Article

References (13)

1. MA Gertz MQ Lacy A Dispenzieri 1999 Amyloidosis Hematol Oncol Clin North Am 13 1211 1233 1:STN:280:DC%2BD3c%2FptFGqsw%3D%3D 10.1016/S0889-8588(05)70122-2 10626146
2. RA Kyle MA Gertz 1995 Primary systemic amyloidosis: clinical and laboratory features in 474 cases Semin Hematol 32 45 59 1:STN:280: DyaK2M7osVShsg%3D%3D 7878478
3. SV Rajkumar A Dispenzieri RA Kyle 2006 Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment Mayo Clin Proc 81 5 693 703 10.4065/81.5.693 16706268
4. SV Rajkumar MA Gertz RA Kyle 1998 Primary systemic amyloidosis with delayed progression to multiple myeloma Cancer 82 1501 1505 1:STN:280: DyaK1c3htlWqsw%3D%3D 10.1002/(SICI)1097-0142(19980415)82:8<1501::AID- CNCR11>3.0.CO;2-8 9554527 (Pubitemid 28164996)
5. Kyle RA (1995) Multiple myeloma and other plasma cell disorders. In: Hoffman R, Benz EJ, Shattil SJ, Cohen FB, LE HJ S (eds) Hematology, basic principles and practice, 2nd edn. Churchill Livingstone, New York, pp 1354-1374
6. KR Desikan MV Dhodapkar A Hough, et al. 1997 Incidence and impact of light chain associated (AL) amyloidosis on the prognosis of patients with multiple myeloma treated with autologous transplantation Leuk Lymphoma 27 315 319 1:STN:280:DyaK1c%2Fmtl2hsg%3D%3D 9402328
7. NJ Bahlis HM Lazarus 2006 Multiple myeloma-associated AL amyloidosis: is a distinctive therapeutic approach warranted? Bone Marrow Transplant 38 1 7 15 1:CAS:528:DC%2BD28XlvFGju70%3D 10.1038/sj.bmt.1705395 16715110 (Pubitemid 43923083)
8. J Vela-Ojeda MA García-Ruiz Esparza Y Padilla-González, et al. 2009 Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor Ann Hematol 88 1 59 66 1:STN:280:DC%2BD1cjlsFemug%3D%3D 10.1007/s00277-008-0554-0 18648809
9. The UK Myeloma Forum AL Amyloidosis Guidelines Working Group 2004 Guidelines on the diagnosis and management of AL amyloidosis Br J Haematol 125 681 700 10.1111/j.1365-2141.2004.04970.x (Pubitemid 38813595)
10. RA Kyle ED Remstein TM Therneau, et al. 2007 Clinical course and prognosis of smoldering (asymptomatic) multiple myeloma N Engl J Med 356 25 2582 2590 1:CAS:528:DC%2BD2sXmslKjsrw%3D 10.1056/NEJMoa070389 17582068 (Pubitemid 46961003)
11. MA Duston M Skinner T Shraham, et al. 1987 Diagnosis of amyloidosis by abdominal fat aspiration: analysis of 4 years experience Am J Med 82 412 414 1:STN:280:DyaL2s7ltlCjtA%3D%3D 10.1016/0002-9343(87)90439-6 2435149
12. F Petruzziello P Zeppa L Catalano, et al. 2010 Amyloid in bone marrow smears of patients affected by multiple myeloma Ann Hematol 89 5 469 474 1:CAS:528:DC%2BC3cXjtlahu7s%3D 10.1007/s00277-009-0857-9 19894050
13. A Solomon DT Weiss AA Kattine, et al. 1991 Nephrotoxic potential of Bence Jones proteins N Engl J Med 324 26 1845 1851 1:STN:280:DyaK3M3ltFyltA%3D%3D 10.1056/NEJM199106273242603 1904132